Skip to main content
FinSpry Logo
FinSpry
QGEN logo
QGEN
(NYSE)
Qiagen N.V.
$42.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Qiagen (QGEN) Stock Price & Financial Analysis

Qiagen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$41.91 - $42.73
52-Week High$57.82
52-Week Low$32.53
Open$42.03
Volume1.10M
Average Volume (3M)2.78M
Market Cap8.88B
Shares Outstanding208.94M
P/E Ratio (TTM)22.08
Forward P/E10.98
Price to Sales (P/S)4.23
Price to Book (P/B)2.67
EV/EBITDA14.22
Revenue (TTM)2.10B
Net Income (TTM)402.17M
Free Cash Flow (TTM)410.54M
EPS (TTM)$1.93
Profit Margin19.16%
Operating Margin25.91%
Return on Equity (ROE)12.07%
Debt to Equity0.49
50-Day MA$42.01
200-Day MA$43.10
52-Week Change-9.65%
Annual Dividend$4.70
Dividend Yield11.06%
Payout Ratio200.00%
Last Dividend Ex-DateJul 7, 2026

Frequently Asked Questions About Qiagen

What is the current stock price for QGEN?

As of the latest trading session, QGEN stock trades at $42.50. The 52-week range is $32.53–$57.82, with a day range of $41.91–$42.73.

What is the P/E ratio for QGEN?

Qiagen's trailing P/E ratio is 22.1, meaning investors pay $22.1 for every $1 of annual earnings. The forward P/E is 11.0, reflecting analyst expectations for future earnings. Qiagen operates in the Healthcare sector.

Does QGEN pay dividends?

Yes, Qiagen pays a 11.06% annual dividend yield ($4.70 per share). The payout ratio is 200.0%. The last ex-dividend date was 2026-07-07.

What do analysts recommend for QGEN?

Based on 10 analysts, the consensus for QGEN is Buy.

What is the market cap of QGEN?

Qiagen's market capitalization is $8.88B, classifying it as a mid-cap company. Qiagen operates in the Healthcare sector within the Diagnostics & Research industry.